PROGENICS PHARMACEUTICALS
Progenics Pharmaceuticals, Inc., of Tarrytown, N.Y., is a biopharmaceutical company focused on innovative therapeutics for patients suffering from cancer and related conditions. Progenics' pipeline candidates include PSMA ADC, a human monoclonal antibody-drug conjugate in phase 2 testing for treatment of prostate cancer, and preclinical stage novel multiplex phosphoinositide 3-kinase (PI3K) inhibitors for the treatment of cancer. Progenics has exclusively licensed development and commercia... lization rights for its first commercial product, RELISTOR®, to Salix Pharmaceuticals, Ltd. for markets worldwide other than Japan, where Ono Pharmaceutical Co., Ltd. holds an exclusive license for the subcutaneous formulation. RELISTOR (methylnaltrexone bromide) Subcutaneous Injection is a first-in-class treatment for opioid-induced constipation approved in more than 50 countries for patients with advanced illness.
PROGENICS PHARMACEUTICALS
Industry:
Biotechnology Health Care
Founded:
1988-01-01
Address:
Tarrytown, New York, United States
Country:
United States
Website Url:
http://www.progenics.com
Total Employee:
51+
Status:
Active
Contact:
9147892800
Email Addresses:
[email protected]
Technology used in webpage:
SPF Domain Not Resolving Microsoft Exchange Online Office 365 Mail IPv6 Microsoft Azure DNS COVID-19 Microsoft Unified Layer MailChimp SPF
Similar Organizations
Canyon Pharmaceuticals
Canyon Pharmaceuticals TM is a privately held, specialty biopharmaceuticals company focused on delivering innovative therapeutic solutions.
Mast Therapeutics
Mast Therapeutics is a biopharmaceutical company developing novel, clinical-stage therapies for serious or life-threatening diseases.
Vigeo Therapeutics
Vigeo Therapeutics is a biopharmaceutical company developing novel therapeutic agents intended to treat advanced malignant tumors.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2015-10-13 | EXINI Diagnostics | EXINI Diagnostics acquired by Progenics Pharmaceuticals | 7 M USD |
| 2013-01-22 | Molecular Insight Pharmaceuticals | Molecular Insight Pharmaceuticals acquired by Progenics Pharmaceuticals | N/A |
Official Site Inspections
http://www.progenics.com Semrush global rank: 5.24 M Semrush visits lastest month: 1.56 K
- Host name: server.xgc.toh.mybluehost.me
- IP address: 96.125.169.163
- Location: Houston United States
- Latitude: 29.8284
- Longitude: -95.4696
- Metro Code: 618
- Timezone: America/Chicago
- Postal: 77092
